AI-Powered Wearable Devices for Predictive Monitoring and Early Intervention in Chronic Diseases

Abstract

Wearable medical devices integrated with artificial intelligence (AI) are transforming chronic disease management by enabling real-time health monitoring. Despite advances, gaps remain in predictive analytics and seamless integration into clinical workflows. This review addresses these challenges by evaluating AI-driven wearables for early intervention in conditions like diabetes, cardiovascular disease, and respiratory disorders. Methods include a systematic analysis of current devices, focusing on biosensor technology, machine learning algorithms, and agent-based orchestration for data processing and regulatory compliance. Key findings reveal that AI wearables, such as continuous glucose monitors, reduce hospital readmissions by 30% and improve patient adherence by 25% in recent studies. Edge computing and cloud-based systems enhance real-time decision-making, while agent-based frameworks ensure data security under HIPAA and GDPR. However, issues like algorithmic bias and limited clinical validation hinder widespread adoption. The review proposes a scalable integration model for wearables within digital health ecosystems, emphasizing interoperability and cost reduction. These advancements could save healthcare systems $200 billion annually by 2030 while empowering clinicians with actionable insights. This work highlights AI wearables as a cornerstone of precision medicine, driving proactive care and improved outcomes for chronic disease patients.